FKBP5 is a Biomarker for Idiopathic Pulmonary Fibrosis based on a Multi-omic Study Integrating xQTLs

Authors

Institutions

Publication Details

Journal
Current Medicinal Chemistry
Published
2026-01-06
DOI
https://doi.org/10.2174/0109298673389211251011085045
Primary Topic
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

FKBP5 is a Biomarker for Idiopathic Pulmonary Fibrosis based on a Multi-omic Study Integrating xQTLs

Yang We, Peng Pan
Current Medicinal Chemistry
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
article

FKBP5 is a Biomarker for Idiopathic Pulmonary Fibrosis based on a Multi-omic Study Integrating xQTLs

Yang We, Peng Pan
article en

Abstract

No abstract available for this paper.
Current Medicinal ChemistryVol. 33
Harbin Medical University (CN), Second Affiliated Hospital of Harbin Medical University (CN)
No poverty
Openalex Percentile: Top 94%
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

FKBP5 is a Biomarker for Idiopathic Pulmonary Fibrosis based on a Multi-omic Study Integrating xQTLs — Yang We, Peng Pan · Current Medicinal Chemistry (2026) | TGRS Research Map | TGRS